Drawing for HELIX

USPTO serial 98679446

HELIX

Reviewed by CopyMark Law Group

Reg. 7886871Status 700Registered
Filing date
Status date
Registration date
Aug 12, 2025
Examiner
RITTNER, HANNO I
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HELIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jami A. Gekas

Jami A. Gekas Foley & Lardner LLP321 North Clark StreetSuite 3000Chicago, IL 60654-4762

Goods and services

ClassDescriptionStatusFirst use
009Downloadable electronic publications in the nature of reports and whitepapers in the field of science; Downloadable electronic publications in the nature of reports and whitepapers in the field of healthcare, bioinformatics, medicine, diagnostics, population health, virology, epidemiology, genomics, biotechnology support, and pharmacogenomics; Electronic downloadable publications, namely, healthcare, bioinformatics, medicine, diagnostics, population health, virology, epidemiology, genomics, biotechnology support, and pharmacogenomics articles for use by medical professionals in the field of science and medicine; Electronic downloadable publications, namely, science articles for use by medical professionals in the field of science and medicineACTIVEJun 28, 2018
010Apparatus for DNA and RNA testing for medical purposes; Diagnostic apparatus for medical purposes used in medical laboratories for testing blood, saliva, and genetic material; Genetic testing apparatus for medical purposes; Medical devices for use in treating or diagnosing genetically-linked conditions, likelihood of developing cancer, pharmacogenomics interactions, and likelihood of developing cardiovascular disease; Medical diagnostic apparatus for testing DNA and RNA samplesACTIVEOct 2, 2018
035Abstracting services in the nature of extracting and summarizing information from medical records; Abstracting services in the nature of extracting and summarizing information from genetic records; Business consulting and information services; Business services provided to the healthcare industry, namely, the collection, reporting, and analysis of healthcare quality data for business purposes; Consulting services in the cost management of health care; Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare; Maintaining patient medical records and files; Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of healthcare, bioinformatics, medicine, diagnostics, biotechnology support, and pharmacogenomics; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of healthcare; Statistical analysis and reporting services for business purposesACTIVEJul 21, 2017
038Electronic exchange of medical records across a nationwide health information network; Providing access to an electronic exchange of medical records across a nationwide health information network; Transmission of podcastsACTIVEJan 29, 2024
041Education services, namely, providing non-downloadable webinars in the field of healthcare, bioinformatics, medicine, diagnostics, population health, virology, epidemiology, genomics, biotechnology support, and pharmacogenomics; Entertainment services, namely, providing podcasts in the field of healthcare, bioinformatics, medicine, diagnostics, population health, virology, epidemiology, genomics, biotechnology support, and pharmacogenomics; Production and distribution of videos in the field of healthcare, bioinformatics, medicine, diagnostics, population health, virology, epidemiology, genomics, biotechnology support, and pharmacogenomics; Production of podcasts; Providing on-line publications in the nature of articles in the field of healthcare, bioinformatics, medicine, diagnostics, biotechnology support, and pharmacogenomics; Publication of documents in the field of training, science, public law and social affairs; Publishing and issuing of scientific papers in the field of healthcare, bioinformatics, medicine, diagnostics, biotechnology support, and pharmacogenomics; Publishing and issuing scientific papers in relation to medical technologyACTIVENov 16, 2018
042Computer services, namely, hosting an interactive web site that allows users to enter, access, track, monitor and generate health and medical information and reports; Consulting services in the field of genetic science; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; Genetic testing for scientific research purposes; Laboratory research in the field of healthcare, bioinformatics, pharmaceuticals, biotechnology support, and gene expression; Medical research; Medical research laboratories; Medical research laboratory services; Platform as a service (PAAS) featuring computer software platforms for managing patient populations for healthcare, diagnostic, and bioinformatics interpretation of health data, and compiling data for research purposes in the field of medical science and medical consultancy for use in connection with diagnostic testing; Providing a website featuring non-downloadable software for accessing, viewing, interacting with and downloading personal health records, diagnoses, treatment plans, and health monitoring information; Providing a website featuring non-downloadable software for patient access to health care services and health, genetic, diagnosis, treatment and health maintenance information; Providing genetic science information; Providing medical and scientific research information; Providing medical testing services and information in the field of cancer research and disease classification; Providing on-line non-downloadable software for health care providers to access information on drug-gene interaction and adverse drug reactions, bioinformatics interpretation of health data, and compiling data for research purposes in the field of medical science and medical consultancy for use in connection with diagnostic testing; Providing scientific research information in the field of healthcare, bioinformatics, and biotechnology support; Research and development in the field of healthcare, medicine, population health programs, bioinformatics, biotechnology support, pharmacogenomics, cardiovascular conditions, and cancer; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research; Scientific research and development; Scientific research consulting; Scientific research consulting in the field of medicine, population health programs, bioinformatics, biotechnology support, pharmacogenomics, cardiovascular conditions, and cancer; Scientific study and research in the field(s) of medicine, population health programs, bioinformatics, biotechnology support, pharmacogenomics, cardiovascular conditions, population health management, and cancer; Software as a service (SAAS) services featuring software for management of patient populations, healthcare, diagnostic support, healthcare record analysis, advising healthcare providers, bioinformatics interpretation of health data, and compiling data for research purposes in the field of medical science and medical consultancy for use in connection with diagnostic testing; Technology consultation in the field of medical researchACTIVEDec 5, 2016
044Healthcare; Blood analysis services being medical analysis services for diagnostic treatment purposes provided by medical laboratories; Blood testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Consulting services in the field of healthcare; Genetic testing for cancer risk for medical purposes; Health care consulting in the field of diagnostic support, cancer screening, cardiovascular conditions, pharmacogenomics, biotechnology support, bioinformatics, and population health; Health care consulting in the field of patient outreach for pharmacogenomics, cardiovascular conditions and cancer screening; Health care services, namely, providing a database in the field of genetics, diagnostic support, cancer, population health, and pharmaceutical information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Health care services, namely, diagnostic testing supporting patient health; Health care services, namely, bioinformatics analysis for medical diagnostic and personalized treatment purposes; Health care services, namely, creating personalized preventative health-care programs and disease management programs; Health care services, namely, leveraging health monitoring and data science to provide optimal health and disease prevention to patients; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical diagnostic services; Medical diagnostic testing, monitoring and reporting services; Medical information services provided via the Internet; Medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient; Medical screening; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of pharmacogenomics, cardiovascular conditions, and cancer; Medical testing services; Providing a web site featuring medical information; Providing cancer screening services; Providing health information via a website; Providing healthcare information; Providing information about genetic testing for medical purposes; Providing medical information to patients and medical professionals in the form of reports in the field of heart disease, cancer, bioinformatics, biotechnology support, and pharmaceutical-gene interactions; Providing medical information, consultancy and advisory services; Providing personalized healthcare and medical information in the nature of custom medical records analysis to inform patients about the range of possible therapies for associated health symptoms, ailments and diseases; Provision of medical information; DNA screening for medical purposesACTIVEDec 5, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 12, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 12, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 20, 2025ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Jun 18, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 18, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 18, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 9, 2025ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Mar 11, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 11, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 5, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 14, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 10, 2025DOCKASSIGNED TO EXAMINER—
Aug 2, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 2, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance